Form 4: NeueHealth Director Kedrick D. Adkins Jr. Reports Stock Transactions
SEC Form 4 Filing
Director Kedrick D. Adkins Jr. reports acquisition and disposal of NeueHealth, Inc. stock and restricted stock units.
Summary
- On May 12, 2024, Kedrick D. Adkins Jr., a director of NeueHealth, Inc., reported transactions involving the company's stock and restricted stock units.
- Adkins disposed of 4,755 shares of common stock.
- Adkins also acquired 4,755 restricted stock units that vested on May 12, 2024.
- On May 13, 2024, Adkins acquired 10,500 restricted stock units that will vest on May 13, 2025.
- Following these transactions, Adkins directly owns 10,500 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to investors regarding the actions of company leadership.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 05/12/2024 | Disposal of 4,755 shares of common stock and vesting of 4,755 restricted stock units. |
| 05/13/2024 | Acquisition of 10,500 restricted stock units vesting on May 13, 2025. |
| 05/13/2025 | Vesting date for 10,500 restricted stock units acquired on May 13, 2024. |
| 05/14/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.